B+
Bull case
20%
Probability
Target price
$16.08
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
CMPS
COMPASS PathwaysFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive late-stage readouts, constructive FDA interactions, and payer traction could re-rate COMPASS toward analyst upside within 12 months.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Binary clinical trial/readout failure
Momentum
82
Value
41
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.17 · Bull $16.08 · Bear $5.48Analysis 2026-02-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $22.71
Why
Momentum82 · Δ7d -4.4
Value41 · Δ7d 0.0
Sentiment15 · Δ7d -1.3
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Binary clinical trial/readout failure
- • Dilution and financing needs
- • Trial failures, regulatory setbacks, or dilutive financings would compress multiples and push the share price materially lower.
Catalyst clock
2026-05-27
Analyst re-ratings / coverage updates
Lead driver: Value · See fundamentals
Momentum
82
9% active weight
Current posture
7d trendSoftening
Δ7d
-4.4
Δ21d
-7.7
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
15
62% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
+1.4
Why this grade
Composite grade F. Momentum 82.0 / Value 41.2 / Sentiment 15.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-26. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$8.17
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$5.48
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.86B
Beta
1.93
Shares Out
135.72M
P/E (TTM) · Derived
-4.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-9.57
Rev YoY
-
EPS YoY
+352.1%
Gross Margin
-
Op Margin
-
Net Debt
-$114.95M
Current Ratio
1.30
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data